- Home
- AVIR vs UROY Comparison
AVIR vs UROY Comparison
Compare AVIR & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- UROY
- Stock Information
- Founded
- AVIR 2012
- UROY 2017
- Country
- AVIR United States
- UROY Canada
- Employees
- AVIR N/A
- UROY N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- UROY
- Sector
- AVIR Health Care
- UROY
- Exchange
- AVIR Nasdaq
- UROY Nasdaq
- Market Cap
- AVIR 284.6M
- UROY 292.6M
- IPO Year
- AVIR 2020
- UROY N/A
- Fundamental
- Price
- AVIR $3.24
- UROY $2.39
- Analyst Decision
- AVIR Hold
- UROY Strong Buy
- Analyst Count
- AVIR 1
- UROY 2
- Target Price
- AVIR $6.88
- UROY $5.60
- AVG Volume (30 Days)
- AVIR 505.9K
- UROY 2.0M
- Earning Date
- AVIR 02-26-2025
- UROY 03-14-2025
- Dividend Yield
- AVIR N/A
- UROY N/A
- EPS Growth
- AVIR N/A
- UROY 256.61
- EPS
- AVIR N/A
- UROY 0.03
- Revenue
- AVIR N/A
- UROY $27,478,292.00
- Revenue This Year
- AVIR N/A
- UROY N/A
- Revenue Next Year
- AVIR N/A
- UROY $34.24
- P/E Ratio
- AVIR N/A
- UROY $87.60
- Revenue Growth
- AVIR N/A
- UROY 31.26
- 52 Week Low
- AVIR $2.75
- UROY $1.86
- 52 Week High
- AVIR $4.60
- UROY $3.76
- Technical
- Relative Strength Index (RSI)
- AVIR 47.81
- UROY 54.77
- Support Level
- AVIR $3.11
- UROY $2.20
- Resistance Level
- AVIR $3.49
- UROY $2.45
- Average True Range (ATR)
- AVIR 0.14
- UROY 0.12
- MACD
- AVIR -0.00
- UROY 0.02
- Stochastic Oscillator
- AVIR 26.58
- UROY 82.28
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.